Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Cannabis operator with vertical operations in Arizona and Ohio, Vext Science, Inc. (CSE:VEXT) (OTCQX:VEXTF) reported its first quarter financial results on Wednesday for the three months ended March 31, 2024.
“The first quarter of 2024 continued to present consumer-related challenges to all operators, with the Arizona market overall experiencing another decline in quarterly revenue,” said Eric Offenberger, CEO of Vext.
Vext's time drove traffic during the quarter "by offering bundled products at the retail level, and outperforming state averages despite impacts on revenue and gross margins," Offenberger continued.
With the recreational marijuana market poised to launch any day now Vext is gearing up to sieze the new opportunity.
That said, Vext announced that it has entered into a loan agreement with certain third-party lenders, including Sopica Special Opportunities Fund Limited, under which it has obtained a standby credit facility in the principal amount of up to $2 million. The mover is expected to provide additional financial flexibility primarily in connection with the company’s working capital investment and dispensary additions in Ohio.
“Ohio presents a significant, multi-year growth opportunity for Vext, and the standby credit line we announced today will offer us additional flexibility to address any short-term funding needs as the adult-use program gains momentum and our cash flow returns to growth following the build-out of our significant presence in the state,” Offenberger continued.
Interest on any drawn portion of the standby credit facility accrues at a rate of 12% annually. All obligations owing under the standby credit facility will be converted into a term loan on Nov. 28, 2024, repayable over six months and maturing on May 28, 2025.
As yet another earnings reporting season wraps up it is important to understand what these figures mean for the future of the industry. Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.
Vext's shares traded 5.08% higher at $0.1842 per share after the market close on Tuesday.
Cannabis Co. Vext Announces Debt Conversion, Opens Door To 27 Million Shares For Investors
Tough Q3 For Cannabis Co. Vext Science, But Ohio Rec Market Launch Holds Promise